MANIPAL HEALTH ENTERPRI L vs Sun Pharmaceutical Industries Ltd

A side-by-side comparison of MANIPAL HEALTH ENTERPRI L (MANIPALHOS) and Sun Pharmaceutical Industries Ltd (SPECTRA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Sun Pharmaceutical Industries Ltd leads MANIPALHOS vs SPECTRA on 11 of 14 metrics (3 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation03
  • Profitability04
  • Growth· not comparable
  • Size & financial health04
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

SPECTRA takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

208.96
P/E ratio
0.09
5.87
P/B ratio
-0.05
0.00%
Dividend yield even
0.00%
₹3.64
EPS
₹45.55

Profitability

SPECTRA takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

8.56%
Return on equity
16.00%
10.20%
Return on capital
20.00%
25.00%
EBITDA margin
29.00%
12.00%
Net margin
20.85%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.17%
Revenue CAGR (3Y) even
30.38%
Profit CAGR (3Y) even

Size & financial health

SPECTRA takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹95,003 Cr
Market cap
₹4.42L Cr
₹3,584 Cr
Revenue
₹52,578 Cr
₹430 Cr
Net profit
₹10,965 Cr
0.48
Debt / equity
0.00
MANIPAL HEALTH ENTERPRI L
  • + ["Company has delivered good profit growth of 26.0% CAGR over last 5 years"]
  • ["Company has a low return on equity of 10.2% over last 3 years."]
Sun Pharmaceutical Industries Ltd
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
  • ["The company has delivered a poor sales growth of 11.8% over past five years."]
MANIPAL HEALTH ENTERPRI L full analysis Sun Pharmaceutical Industries Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.